Zusammenfassung
Hintergrund
Der künstlichen Intelligenz (KI) wird das Potenzial zugeschrieben, die medizinische Arbeitsweise in den kommenden Dekaden nachhaltig zu verändern. Die radiologische Bildgebung stellt hierbei eines der Hauptanwendungsgebiete dar.
Ziel der Arbeit
In diesem Artikel werden bisherige KI-Entwicklungen mit dem Fokus auf die onkologische Radiologie zusammengefasst und an ausgewählten Beispielen mögliche Szenarien für die Entwicklung in den kommenden 10 Jahren abgeleitet.
Material und Methoden
Diese Arbeit basiert auf einer Recherche in verschiedenen Literatur- und Produktdatenbanken, Veröffentlichungen von regulatorischen Behörden und Berichten im Internet.
Schlussfolgerung
Der klinische Einsatz von KI-Anwendungen befindet sich noch in einer frühen Entwicklungsphase. Die große Anzahl an Forschungspublikationen demonstriert das Potenzial dieses Gebiets. Auch stehen den Anwendern bereits erste zertifizierte Produkte zur Verfügung. Für eine flächendeckende Verbreitung von KI-Anwendungen in der klinischen Routine sind jedoch noch einige grundlegende Voraussetzungen zu schaffen. Zu diesen gehören die Generierung von Evidenz für den Einsatz von Algorithmen anhand repräsentativer klinischer Studien, Anpassungen der Rahmenbedingungen für die Zulassung sowie eine gezielte Aus- und Weiterbildung der Anwender. Es ist zu erwarten, dass KI-Methoden künftig zunehmend eingesetzt und damit neue Möglichkeiten für eine bessere Diagnostik und Therapie sowie ein effizienteres Arbeiten geschaffen werden.
Abstract
Background
Artificial intelligence (AI) has the potential to fundamentally change medicine within the coming decades. Radiological imaging is one of the primary fields of its clinical application.
Objectives
In this article, we summarize previous AI developments with a focus on oncological radiology. Based on selected examples, we derive scenarios for developments in the next 10 years.
Materials and methods
This work is based on a review of various literature and product databases, publications by regulatory authorities, reports, and press releases.
Conclusions
The clinical use of AI applications is still in an early stage of development. The large number of research publications shows the potential of the field. Several certified products have already become available to users. However, for a widespread adoption of AI applications in clinical routine, several fundamental prerequisites are still awaited. These include the generation of evidence justifying the use of algorithms through representative clinical studies, adjustments to the framework for approval processes and dedicated education and teaching resources for its users. It is expected that use of AI methods will increase, thus, creating new opportunities for improved diagnostics, therapy, and more efficient workflows.
Notes
Durch die Autoren dieses Artikels eingeteilt.
Literatur
Reardon S Rise of robot radiologists. In: Sci. Am. https://www.scientificamerican.com/article/rise-of-robot-radiologists/. Zugegriffen: 1. Nov. 2020
Alexander A, Jiang A, Ferreira C, Zurkiya D (2020) An intelligent future for medical imaging: a market outlook on artificial intelligence for medical imaging. J Am Coll Radiol 17:165–170
Ugalmugle S (2019) AI in Healthcare Market size to exceed $13 Bn by 2025. Global Market Insights. https://www.gminsights.com/. Zugegriffen: 1. Nov. 2020
Artificial Intelligence in Healthcare Market with Covid-19 Impact Analysis by Offering (Hardware, Software, Services), Technology (Machine Learning, NLP, Context-Aware Computing, Computer Vision), End-Use Application, End User and Region – Global Forecast to 2026. 246
Columbus L (2020) What’s new in Gartner’s hype cycle for AI, 2020. In: Forbes. https://www.forbes.com/sites/louiscolumbus/2020/10/04/whats-new-in-gartners-hype-cycle-for-ai-2020/#2ad095c8335c. Zugegriffen: 28. Okt. 2020
McCarthy J, Minsky ML, Rochester N, Shannon CE (2006) A proposal for the Dartmouth summer research project on artificial intelligence, August 31, 1955. Al Mag 27:12–12
Roellinger FX, Kahveci AE, Chang JK, Harlow CA, Dwyer SJ, Lodwick GS (1973) Computer analysis of chest radiographs. Comput Graph Image Process 2:232–251
Kruger RP, Thompson WB, Turner AF (1974) Computer diagnosis of pneumoconiosis. IEEE Trans Syst Man Cybern SMC 4:40–49
Lecun Y, Bottou L, Bengio Y, Haffner P (1998) Gradient-based learning applied to document recognition. Proc IEEE 86:2278–2324
Hamilton JG, Genoff Garzon M, Westerman JS et al (2019) “A tool, not a crutch”: patient perspectives about IBM watson for oncology trained by memorial Sloan Kettering. J Oncol Pract 15:e277–e288
Somashekhar SP, Sepúlveda M‑J, Puglielli S et al (2018) Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol 29:418–423
Zhao X, Zhang Y, Ma X et al (2020) Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China. Jpn J Clin Oncol 50:852–858
Strickland E (2019) IBM Watson, heal thyself: how IBM overpromised and underdelivered on AI health care. IEEE Spectr 56:24–31
Schmidt C (2017) M. D. Anderson breaks with IBM watson, raising questions about artificial intelligence in oncology. JNCI J Natl Cancer Inst. https://doi.org/10.1093/jnci/djx113
Brown TB, Mann B, Ryder N et al (2020) Language models are few-shot learners. ArXiv200514165Cs
ImageNet Large Scale Visual Recognition Competition 2012 (ILSVRC2012). http://www.image-net.org/challenges/LSVRC/2012/results.html. Zugegriffen: 29 Okt. 2020
Krizhevsky A, Sutskever I, Hinton GE (2017) ImageNet classification with deep convolutional neural networks. Commun ACM 60:84–90
Treanor J (2015) The 2010 “flash crash”: how it unfolded. The Guardian
The Medical Futurist https://medicalfuturist.com/fda-approved-ai-based-algorithms/. Zugegriffen: 28. Okt. 2020
Benjamens S, Dhunnoo P, Meskó B (2020) The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. Npj Digit Med 3:1–8
AI for radiology. https://grand-challenge.org/aiforradiology/. Zugegriffen: 28 Okt. 2020
FDA Cleared AI Algorithms. https://www.acrdsi.org/DSI-Services/FDA-Cleared-AI-Algorithms. Zugegriffen: 28 Okt. 2020
(2020) Comments of the American College of Radiology on “Public Workshop—Evolving Role of Artificial Intelligence in Radiological Imaging;” Docket No. FDA-2019-N-5592:
FDA Cleared AI Algorithms. https://www.acrdsi.org/DSI-Services/FDA-Cleared-AI-Algorithms. Zugegriffen: 28 Okt. 2020
(2020) Change healthcare artificial intelligence decreases administrative burden of case management. In: Imaging Technol. News. https://www.itnonline.com/content/change-healthcare-artificial-intelligence-decreases-administrative-burden-case-management. Zugegriffen: 31. Okt. 2020
Advanced intelligent Clear-IQ Engine (AiCE) | MRI | Magnetic Resonance Imaging | Canon Medical Systems USA. https://us.medical.canon/products/magnetic-resonance/aice/. Zugegriffen: 1 Nov. 2020
Uetani H, Nakaura T, Kitajima M et al (2020) A preliminary study of deep learning-based reconstruction specialized for denoising in high-frequency domain: usefulness in high-resolution three-dimensional magnetic resonance cisternography of the cerebellopontine angle. Neuroradiology. https://doi.org/10.1007/s00234-020-02513-w
Subtle Medical—Deep Learning boosts healthcare. Faster, Safer, Smarter. https://subtlemedical.com/. Zugegriffen: 1 Nov. 2020
Viz Ischemic Stroke Platform. https://www.viz.ai/ischemic-stroke. Zugegriffen: 1 Nov. 2020
Radiology AI | Aidoc Always-on AI. In: Aidoc. https://www.aidoc.com/. Zugegriffen: 1 Nov. 2020
Combinostics, cNeuro® cMRI. Fully automated solution for quantifying MR brain scans. https://www.cneuro.com/cmri/. Zugegriffen: 01. Nov. 2020
Kann BH, Thompson R, Thomas CR, Dicker A, Aneja S (2019) Artificial intelligence in oncology: current applications and future directions. Oncology 33:46–53
Dunn WD, Aerts HJWL, Cooper LA et al (2016) Assessing the effects of software platforms on volumetric segmentation of Glioblastoma. J Neuroimaging Psychiatry Neurol 1:64–72
Raghu VK, Zhao W, Pu J, Leader JK, Wang R, Herman J, Yuan J‑M, Benos PV, Wilson DO (2019) Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models. Thorax 74:643–649
Lu MT, Rosman DA, Wu CC, Gilman MD, Harvey HB, Gervais DA, Alkasab TK, Shepard J‑AO, Boland GW, Pandharipande PV (2016) Radiologist point-of-care clinical decision support and adherence to guidelines for incidental lung nodules. J Am Coll Radiol 13:156–162
Quantib Receives FDA Clearance for First-to-Market Prostate Solution | Imaging Technology News. https://www.itnonline.com/content/quantib-receives-fda-clearance-first-market-prostate-solution. Zugegriffen: 1 Nov. 2020
Ezra Receives FDA Clearance for Prostate Cancer Artificial Intelligence. https://www.prnewswire.com/news-releases/ezra-receives-fda-clearance-for-prostate-cancer-artificial-intelligence-301154585.html. Zugegriffen: 31 Okt. 2020
Magazine ICE (2020) FDA clears transpara 3D
Salim M, Wåhlin E, Dembrower K, Azavedo E, Foukakis T, Liu Y, Smith K, Eklund M, Strand F (2020) External evaluation of 3 commercial artificial intelligence algorithms for independent assessment of screening mammograms. JAMA Oncol 6:1581–1588
cmTriage FDA Cleared—CureMetrix—2D Mammogram. CureMetrix
Inform AI | Advancing Healthcare Through Analytics. https://www.informai.com/. Zugegriffen: 1 Nov. 2020
Arterys Marketplace. https://marketplace.arterys.com/clinicalApp/lungapp. Zugegriffen: 1 Nov. 2020
Fujifilm’s New AI-based Technology for Lung Nodule Detection Now Approved for Use in Japan. In: Fujifilm Glob. https://www.fujifilm.com/news/n200527_01.html. Zugegriffen: 1 Nov. 2020
Lo SB, Freedman MT, Gillis LB, White CS, Mun SK (2018) JOURNAL CLUB: computer-aided detection of lung nodules on CT with a computerized pulmonary vessel suppressed function. Am J Roentgenol 210:480–488
Lung AI. Arterys Marketplace. https://marketplace.arterys.com/clinicalApp/lungapp/. Zugegriffen: 1. Nov. 2020
AI Radiology Solutions Request a Demo Today! In: Oxipit. https://oxipit.ai/. Zugegriffen: 1. Nov. 2020
Liang C‑H, Liu Y‑C, Wu M‑T, Garcia-Castro F, Alberich-Bayarri A, Wu F‑Z (2020) Identifying pulmonary nodules or masses on chest radiography using deep learning: external validation and strategies to improve clinical practice. Clin Radiol 75:38–45
Tandel GS, Biswas M, Kakde OG et al (2019) A review on a deep learning perspective in brain cancer classification. Cancers 11:111
Geras KJ, Mann RM, Moy L (2019) Artificial intelligence for mammography and digital breast tomosynthesis: current concepts and future perspectives. Radiology 293:246–259
Houssami N, Kirkpatrick-Jones G, Noguchi N, Lee CI (2019) Artificial Intelligence (AI) for the early detection of breast cancer: a scoping review to assess AI’s potential in breast screening practice. Expert Rev Med Devices 16:351–362
Bardis MD, Houshyar R, Chang PD, Ushinsky A, Glavis-Bloom J, Chahine C, Bui T‑L, Rupasinghe M, Filippi CG, Chow DS (2020) Applications of artificial intelligence to prostate multiparametric MRI (mpMRI): current and emerging trends. Cancers. https://doi.org/10.3390/cancers12051204
Chassagnon G, Vakalopoulou M, Paragios N, Revel M‑P (2020) Artificial intelligence applications for thoracic imaging. Eur J Radiol 123:108774
Hamm CA, Wang CJ, Savic LJ et al (2019) Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI. Eur Radiol 29:3338–3347
Wang CJ, Hamm CA, Savic LJ et al (2019) Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features. Eur Radiol 29:3348–3357
Nagendran M, Chen Y, Lovejoy CA, Gordon AC, Komorowski M, Harvey H, Topol EJ, Ioannidis JPA, Collins GS, Maruthappu M (2020) Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies. BMJ. https://doi.org/10.1136/bmj.m689
Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms—Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03706534. Zugegriffen: 29 Okt. 2020
Langlotz CP, Allen B, Erickson BJ et al (2019) A roadmap for foundational research on artificial intelligence in medical imaging: from the 2018 NIH/RSNA/ACR/the academy workshop. Radiology 291:781–791
The SPIRIT-AI and CONSORT-AI Working Group, Liu X, Rivera CS, Moher D, Calvert MJ, Denniston AK (2020) Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat Med 26:1364–1374
Pianykh OS, Langs G, Dewey M, Enzmann DR, Herold CJ, Schoenberg SO, Brink JA (2020) Continuous learning AI in radiology: implementation principles and early applications. Radiology 297:6–14
Health C for D and R (2020) Digital Health Software Precertification (Pre-Cert) Program. In: FDA. https://www.fda.gov/medical-devices/digital-health-center-excellence/digital-health-software-precertification-pre-cert-program. Zugegriffen: 15. Nov. 2020
Geis JR, Brady AP, Wu CC et al (2019) Ethics of artificial intelligence in radiology: summary of the joint European and north American Multisociety statement. Radiology 293:436–440
Magrabi F, Ammenwerth E, McNair JB et al (2019) Artificial intelligence in clinical decision support: challenges for evaluating AI and practical implications: a position paper from the IMIA technology assessment & quality development in health Informatics working group and the EFMI working group for assessment of health information systems. Yearb Med Inform 28:128–134
Codari M, Melazzini L, Morozov SP, van Kuijk CC, Sconfienza LM, Sardanelli F, European Society of Radiology (2019) Impact of artificial intelligence on radiology: a EuroAIM survey among members of the European Society of Radiology. Insights Imaging 10:105
Kohli A, Jha S (2018) Why CAD failed in mammography. J Am Coll Radiol 15:535–537
Lehman CD, Wellman RD, Buist DSM, Kerlikowske K, Tosteson ANA, Miglioretti DL (2015) Diagnostic accuracy of digital screening mammography with and without computer-aided detection. JAMA Intern Med 175:1828
Commissioner O of the (2020) FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems. In: FDA. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye. Zugegriffen: 31. Okt. 2020
Viz.ai Viz.ai Granted Medicare New Technology Add-on Payment. https://www.prnewswire.com/news-releases/vizai-granted-medicare-new-technology-add-on-payment-301123603.html. Zugegriffen: 31 Okt. 2020
Hassan AE, Ringheanu VM, Rabah RR, Preston L, Tekle WG, Qureshi AI (2020) Early experience utilizing artificial intelligence shows significant reduction in transfer times and length of stay in a hub and spoke model. Interv Neuroradiol 26:615–622
https://kurzweilai.net Artificial intelligence, human brain to merge in 2030s, says futurist Kurzweil Kurzweil. Zugegriffen: 1. Nov. 2020
Dewey M (2018) The future of radiology: adding value to clinical care. Lancet 392:472–473
Huang S‑C, Pareek A, Seyyedi S, Banerjee I, Lungren MP (2020) Fusion of medical imaging and electronic health records using deep learning: a systematic review and implementation guidelines. Npj Digit Med 3:136
Arimura H, Soufi M, Kamezawa H, Ninomiya K, Yamada M (2019) Radiomics with artificial intelligence for precision medicine in radiation therapy. J Radiat Res 60:150–157
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A.M. Bucher und J. Kleesiek geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Rights and permissions
About this article
Cite this article
Bucher, A.M., Kleesiek, J. Künstliche Intelligenz in der onkologischen Radiologie. Radiologe 61, 52–59 (2021). https://doi.org/10.1007/s00117-020-00787-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-020-00787-y
Schlüsselwörter
- Deep Learning
- Maschinelles Lernen
- Regulatorische Angelegenheiten
- Digitale Transformation
- Kommerzielle Software